Citation:Jiang J, Liang X, Zhou X, Huang R, Chu Z 2007

Citation

Jiang J, Liang X, Zhou X, Huang R, Chu Z. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Lung Cancer 2007 Sep;57(3):348-58 Available from: http://www.ncbi.nlm.nih.gov/pubmed/17485133.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Jiang J, Liang X, Zhou X, Huang R, Chu Z 2007	What is the optimal systemic therapy for stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed
Jiang J, Liang X, Zhou X, Huang R, Chu Z 2007 2	What is the optimal first-line chemotherapy regimen in patients with stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed
Jiang J, Liang X, Zhou X, Huang R, Chu Z 2007 3	Is carboplatin based chemotherapy as effective as cisplatin based chemotherapy for treatment of stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?|]] (compare critical appraisals)
• [[Clinical question:What is the optimal first-line chemotherapy regimen in patients with stage IV inoperable NSCLC?|]] (compare critical appraisals)
• [[Clinical question:Is carboplatin based chemotherapy as effective as cisplatin based chemotherapy for treatment of stage IV inoperable NSCLC?|]] (compare critical appraisals)

Cited by

1. Is carboplatin based chemotherapy as effective as cisplatin based chemotherapy for treatment of stage IV inoperable NSCLC?
2. What is the optimal systemic therapy for stage IV inoperable NSCLC?